The Anti-COVID Antibiotic
In the very turbulent first year of this decade, AZITHROMYCIN®, a 40-year-old drug, has almost become a household name, being the subject of over 66,000 news media articles. Is it being unfairly demonized because it's a cheap, effective drug competing with big pharma's patented +$2000 drug, Remdesivir? Does it deserve a place in the antifragile Biohacker's anti-COVID tool chest?